Anticoagulant Added Patents (Class 604/6.07)
-
Publication number: 20120053501Abstract: Methods and systems are provided for anticoagulating blood. Whole blood is drawn from a donor into a system at a draw flow rate. Anticoagulant from an anticoagulant source is pumped into the system at an anticoagulant flow rate to mix with the blood. The anticoagulated blood may be subsequently processed in any of a number of known ways, including separating it and removing at least a portion of one of the components of the blood. Thereafter, at least a portion of the remaining blood may be returned to the donor. The anticoagulant flow rate is independent of the draw flow rate and can be based on a number of factors, including the weight of the donor and the rate at which the donor can metabolize the anticoagulant.Type: ApplicationFiled: August 24, 2010Publication date: March 1, 2012Inventor: Richard I. Brown
-
Patent number: 8109893Abstract: A patient wearable, continuously operating extracorporeal pump apparatus which accesses the patient's arterial venous pressure differential by applying external pressure to a subcutaneous graft that has been cannualized to modulate blood flow through an extracorporeal circuit and to drive the pump for delivering a medicament, such as an anticoagulant, to the site of an intravenous cannula to prevent clogging thereof and also to move a dialysate through a circuit, including a dialyzer and a dialysate rejuvenating cartridge, whereby kidney failure can be treated without recourse to prior art hemodialysis machines found in most treatment facilities. With slight modification, the present invention can be used to remove excess fluids from CHF patients, to remove toxins from the blood in those suffering from liver failure and to facilitate administration of insulin to diabetics and/or glucose to those having hypoglycemia.Type: GrantFiled: December 19, 2007Date of Patent: February 7, 2012Inventor: Arnold J. Lande
-
Patent number: 8105258Abstract: A hemofiltration system and method for pumping blood from a patient's blood stream into an access line, introducing an anticoagulant solution into the pumped blood, filtering the pumped blood and delivering it to a return line, introducing a substitution fluid into the pumped blood, introducing a calcium and magnesium solution into the blood traveling through the return line, and returning the blood back to the patient's blood stream.Type: GrantFiled: November 21, 2006Date of Patent: January 31, 2012Assignees: Baxter International Inc., Baxter Healthcare S.A.Inventor: Jean-Michel Lannoy
-
Publication number: 20120022423Abstract: The present invention concerns a multipart fluid system for use in CRRT, wherein the multipart fluid system comprises an anticoagulation fluid and at least one fluid from the group consisting of a dialysis fluid and an infusion fluid. According to the invention the anticoagulation fluid comprises at least 8 mM citrate, and the dialysis fluid and/or infusion fluid comprises 2-8 mM citrate and 1-5 mM total calcium. The present invention further concerns a system for regional citrate anticoagulation in an extracorporeal blood circuit.Type: ApplicationFiled: March 31, 2010Publication date: January 26, 2012Applicant: GAMBRO LUNDIA ABInventor: Jan Sternby
-
Publication number: 20110288464Abstract: A system or method automates and optimizes citrate anticoagulant supplementation in a blood filtration circuit during CRRT. A processor-based control system interfaces with a blood filtration circuit to detect patient blood flow into the circuit, detect fluid loss through a hemofilter, and sense vital electrolyte concentrations in the blood flow, and in response, control the addition of citrate, substitution fluid, and electrolyte supplements to ensure stability of plasma concentrations in post-dilution flow returned to the patient. The controller executes the method embodied as process control algorithms for calculating an optimal citrate flow rate as a function of selected, detected, and calculated system parameters. Citrate may be added to the circuit separately, or as part of a substitution solution or a dialysate.Type: ApplicationFiled: June 30, 2011Publication date: November 24, 2011Applicants: BAXTER HEALTHCARE S.A., BAXTER INTERNATIONAL INC.Inventor: Jean-Michel Lannoy
-
Patent number: 8052667Abstract: The present invention provides modified platelets having a reduced platelet clearance and methods for reducing platelet clearance. Also provided are compositions for the preservation of platelets. The invention also provides methods for making a pharmaceutical composition containing the modified platelets and for administering the pharmaceutical composition to a mammal to mediate hemostasis.Type: GrantFiled: September 7, 2005Date of Patent: November 8, 2011Assignee: Velico Medical, Inc.Inventors: Keith Rosiello, Henrik Clausen
-
Publication number: 20110264025Abstract: A system or method automates and optimizes citrate anticoagulant supplementation in a blood filtration circuit during CRRT. A processor-based control system interfaces with a blood filtration circuit to detect patient blood flow into the circuit, detect fluid loss through a hemofilter, and sense vital electrolyte concentrations in the blood flow, and in response, control the addition of citrate, substitution fluid, and electrolyte supplements to ensure stability of plasma concentrations in post-dilution flow returned to the patient. The controller executes the method embodied as process control algorithms for calculating an optimal citrate flow rate as a function of selected, detected, and calculated system parameters. Citrate may be added to the circuit separately, or as part of a substitution solution or a dialysate.Type: ApplicationFiled: June 30, 2011Publication date: October 27, 2011Applicants: BAXTER HEALTHCARE S.A., BAXTER INTERNATIONAL INC.Inventor: Jean-Michel Lannoy
-
Patent number: 8034015Abstract: A method for maintaining clear passageways in an extracorporeal blood flow system. The method comprises intermittently providing one or more anti-clotting agents to a passageway of the extracorporeal blood flow system. Also disclosed is an extracorporeal blood flow system. The system comprises a passageway, and a device operatively connected to provide one or more anti-clotting agents to a least a portion of said passageway.Type: GrantFiled: April 28, 2008Date of Patent: October 11, 2011Assignee: OptiScan Biomedical CorporationInventors: James R. Braig, Richard Keenan
-
Publication number: 20110237996Abstract: A method of performing regional citrate anticoagulant dialysis of a patient's blood includes flowing blood from and back to the patient through an extracorporeal circuit including a dialyzer having semi-permeable dialysis membranes and a dialysate chamber surrounding the membranes. The method further includes flowing a dialysate containing calcium and citrate through the dialysate chamber of the dialyzer and introducing citrate into the patient's blood upstream of the dialyzer, whereby the patient's blood is dialyzed. The method can further include predicting the concentration of systemic ionized calcium in the blood of the patient at any point in the dialysis treatment or post-dialysis, such as by a mathematical model. The method can further include statistically correcting the preliminary predicted post-dialysis concentration of systemic ionized calcium in the patient's blood to provide a final predicted post-dialysis systemic ionized calcium concentration.Type: ApplicationFiled: June 17, 2010Publication date: September 29, 2011Applicant: Fresenius Medical Care Holdings, Inc.Inventors: Peter Kotanko, Stephan Thijssen, Nathan W. Levin
-
Patent number: 7879000Abstract: The invention concerns a method of collecting a biological fluid, in particular blood, with an anticoagulant and/or preservation solution added, in which the biological fluid is collected by natural flow and the anticoagulant and/or preservation solution is added by pumping, the method making provision for measuring the flow of fluid collected and slaving the pumping speed to the measured flow, so as to obtain continuously during collection a given ratio between the quantity of fluid collected and the quantity of anticoagulant and/or preservation solution added. The invention also concerns a collection machine and bag system for implementing the method.Type: GrantFiled: December 31, 2003Date of Patent: February 1, 2011Assignee: MacopharmaInventors: Maurice Behague, Francis Goudaliez, Thierry Verpoort
-
Publication number: 20100200506Abstract: A renal failure therapy system includes a blood pump; a citrate pump; and a control unit configured to automatically control the blood pump and the citrate pump to achieve a citrate flowrate that is based on a blood flowrate, so that the flowrates are synchronized.Type: ApplicationFiled: April 20, 2010Publication date: August 12, 2010Applicants: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE S.A.Inventors: Lee C. Ware, Arnold F. Boehnlein
-
Publication number: 20100185134Abstract: Artificial kidney for gradual, and at least semi-continuous, blood treatment, wherein a blood stream is fed from a body of a living human or animal being into the artificial kidney, where anticoagulation is first effected, blood cells and molecules of large and medium molecular weight, such as proteins, are then primarily separated from plasma and fed back to the blood stream, regulating a water and salt balance by diverting excess plasma water and further removing from the blood stream, plasma or plasma water accumulated and toxic substances, by removal of specific electrolytes and waste products and wherein purified or partially purified plasma and plasma water is being carried back to the blood tract of the body.Type: ApplicationFiled: June 16, 2008Publication date: July 22, 2010Applicant: Relitech B.V.Inventors: Franciscus Peter Houwen, Henk Van Middendorp, Jacobus Cornelis Musters
-
Publication number: 20100130905Abstract: This invention relates to a method for checking the correct coupling of an adding device to a therapeutic appliance, which includes an extracorporeal circuit with which the adding device is connected such that a drug can be introduced into the extracorporeal circuit by means of the adding device during operation of the therapeutic appliance, wherein the adding device is coupled to the extracorporeal circuit on the suction side of a pump disposed in the extracorporeal circuit, wherein a portion in the region of negative pressure of the extracorporeal circuit in connection with a portion of the adding device is closed with respect to the other parts of the extracorporeal circuit, and wherein the pressure in this closed portion is varied and measured.Type: ApplicationFiled: May 13, 2008Publication date: May 27, 2010Inventors: Thomas Nürnberger, Marco Blasek, Peter Klöffel
-
Publication number: 20100114001Abstract: An extracorporeal blood processing method using a blood circuit comprising a pair of blood passages attached to opposite flow ends of a blood treatment device and said blood circuit is mounted on a blood pump console, the method includes: withdrawing blood from a vascular system of a human patient and drawing the blood into the blood circuit; pumping the withdrawn blood through one of the pair of blood passages using a first blood pump of the console and into the blood treatment device; pumping the treated blood from the treatment device through the other of the pair of blood passages using a second blood pump of the console; infusing the treated blood from the other blood passage and into the vascular system of the patient, and periodically reversing a flow direction of blood through the pair of blood passages and blood treatment device.Type: ApplicationFiled: November 6, 2009Publication date: May 6, 2010Applicant: CHF Solutions, Inc.Inventor: John J. O'Mahony
-
Patent number: 7708710Abstract: Methods are disclosed for collecting and separating whole blood into one or more components. A disposable blood separation fluid circuit is provided which is adapted to cooperate with a reusable separation controller. The fluid circuit includes a fluid flow path for communication with a blood source and at least one container in fluid communication with the fluid flow path. The fluid flow path is connected to a blood source and quantities of whole blood are collected in the container and one other location within the fluid circuit. The source is then disconnected from the disposable fluid circuit. The quantities of whole blood are centrifugally processed, with processing of at least a portion of one of the quantities beginning after the source is disconnected from the fluid circuit.Type: GrantFiled: April 16, 2004Date of Patent: May 4, 2010Assignee: Fenwal, Inc.Inventors: Kyungyoon Min, Richard I. Brown
-
Patent number: 7674235Abstract: A dialyzer having a hemo-dialyzer and/or a hemo-filter and an extra-corporal blood circulation with which a device for the adding of citrate to the blood is connected upstream and a device for the adding of a substitution solution containing ions to the blood is connected downstream of the hemo-dialyzer and/or of the hemo-filter. Ion concentration in the dialyzate downstream of the hemo-dialyzer and/or of the hemo-filter is detected with respect to the direction of flow of the dialyzate. The concentration of the ion, atom or molecule to be determined is reliably ascertained by preventing the complexing of the ion, atom or molecule, at least during the determination of the concentration, by the addition or withdrawal of a substance.Type: GrantFiled: June 9, 2005Date of Patent: March 9, 2010Assignee: Fresenuis Medical Care Deutschland GmbHInventors: Volker Nier, Matthias Kraemer
-
Publication number: 20100022936Abstract: An ultrafiltration device adapted to be worn on a portion of the body of a patient includes a blood inlet tube leading from a first blood vessel, a blood pump, an anticoagulant reservoir for infusing anticoagulants into the blood, a blood filter including a substrate through which the blood is circulated and filtered, a fluid bag for storing the excess fluid and a blood outlet tube leading to a second blood vessel.Type: ApplicationFiled: October 6, 2009Publication date: January 28, 2010Applicant: NATIONAL QUALITY CARE, INC.Inventors: VICTOR GURA, EDMOND RAMBOD
-
Publication number: 20100004579Abstract: The invention relates to a method for the filling of a metering apparatus of a therapy device having an extracorporeal circuit with which the metering apparatus is in communication such that an agent can be infused into the extracorporeal circuit during the operation of the therapy device by means of the metering device, with the method comprising the step of the dilution of a concentrate located in the metering apparatus, wherein the dilution of the concentrate located in the metering apparatus takes place in that the metering apparatus takes up the diluting agent from the extracorporeal circuit in the condition connected to the extracorporeal circuit.Type: ApplicationFiled: August 23, 2007Publication date: January 7, 2010Inventor: Pascal Kopperschmidt
-
Publication number: 20090259163Abstract: A blood processing system for collecting and exchanging blood components includes a venous-access device for drawing whole blood from a subject and returning blood components to the subject. The system may also include three lines connecting the venous access device to a blood component separation device and an anticoagulant source. A blood draw line fluidly connects to the venous-access device to the blood component separation device. An anticoagulant line connected to an anticoagulant source, introduces anticoagulant into the drawn whole blood. A return line, fluidly connected to the venous-access device and the blood component separation device, and returns uncollected blood component to the subject. A draw pump, an anticoagulant pump, and a return pump, respectively control the flows through the draw line, anticoagulant line, and the return line. The blood component separation device separates the drawn blood into a first blood component and a second blood component.Type: ApplicationFiled: April 14, 2008Publication date: October 15, 2009Inventors: Etienne Pages, Michael Ragusa
-
Publication number: 20090221948Abstract: The present invention includes a comprehensive replacement fluid system and method for the delivery of regional citrate anticoagulation (RCA) to extracorporeal blood circuits, wherein the system may include an online clearance monitor (OCM) and a circuit effluent online sensor system (OSS) for the continuous determination of patient plasma content of ultrafilterable soultes.Type: ApplicationFiled: February 22, 2007Publication date: September 3, 2009Applicant: HENRY FORD HEALTH SYSTEMInventors: Balazs Szamosfalvi, Stanley Frinak, Jerry Yee
-
Patent number: 7566315Abstract: A blood component collection apparatus comprises a blood component collecting circuit which includes an anticoagulant line for feeding an anticoagulant and a line for collecting an initial flow of collected blood. In the blood component collection apparatus, air is intermediately present between the anticoagulant and the blood in the passage of a blood collection needle side line, after a priming operation is performed in which anticoagulant is supplied from the anticoagulant line toward the side of a centrifugal separator in the blood collection needle side line through a branch connector and after an initial flow collecting operation is performed in which the initial flow of blood is collected.Type: GrantFiled: June 16, 2006Date of Patent: July 28, 2009Assignee: Terumo Kabushiki KaishaInventor: Makoto Hirabuki
-
Publication number: 20090143711Abstract: A method for maintaining clear passageways in an extracorporeal blood flow system. The method comprises intermittently providing one or more anti-clotting agents to a passageway of the extracorporeal blood flow system. Also disclosed is an extracorporeal blood flow system. The system comprises a passageway, and a device operatively connected to provide one or more anti-clotting agents to a least a portion of said passageway.Type: ApplicationFiled: April 28, 2008Publication date: June 4, 2009Inventors: James R. Braig, Richard Keenan
-
Patent number: 7531094Abstract: The present invention relates to a system for two-stage blood dialysis of a patient. In one embodiment, the system comprises a first filtration device for receiving the blood from the patient and for producing a first filtrate and processed blood. The system further comprises a second filtration device for receiving the first filtrate and producing replacement fluid and waste product. At least one of the first and second filtration devices preferably comprises a Taylor vortex-enhanced blood filtration device.Type: GrantFiled: April 21, 2008Date of Patent: May 12, 2009Assignee: KKJ, Inc.Inventors: Jennifer K. McLaughlin, Don Schoendorfer
-
Publication number: 20090105629Abstract: A blood circuit assembly for a dialysis unit may include an organizing tray, a pair of pneumatic pumps mounted to the organizing tray for circulating blood received from a patient through a circuit including a dialyzer unit and returned to the patient, an air trap mounted to the organizing tray arranged to remove air from blood circulating in the circuit, a pair of dialyzer connections arranged to connect to the inlet and outlet of a dialyzer unit, and a pair of blood line connectors, one inlet blood line connector for receiving blood from the patient and providing blood to the pneumatic pumps and the other outlet blood line connector for returning blood to the patient.Type: ApplicationFiled: August 27, 2008Publication date: April 23, 2009Applicant: DEKA Products Limited PartnershipInventors: Kevin L. Grant, James D. Dale, Michael J. Wilt, Jason A. Demers, David E. Collins
-
Patent number: 7503901Abstract: The invention concerns a bag system for collecting a biological fluid the system intended for use in a collection machine including a peristaltic pump, the system including, in closed circuit, a fluid collection device, a solution bag containing an anticoagulant and/or preservation solution, and a collection bag intended to receive the fluid collected with the anticoagulant and/or preservation solution added. The collection bag is in fluid communication with the collection device by way of a first tube provided with a connector and with the solution bag by way of a second tube connected to the connector. A device for associating the first and second tubes is provided to allow, between the connector and the association device, the formation of a loop with the second tube, the conformation of the loop being arranged to enable it to be disposed around at least part of a head of a peristaltic pump.Type: GrantFiled: December 31, 2003Date of Patent: March 17, 2009Assignee: MacoPharmaInventors: Maurice Behague, Francis Goudaliez, Thierry Verpoort
-
Patent number: 7465285Abstract: A control deck and system for controlling and driving blood fluids through an extracorporeal blood circuit kit. In one aspect, the invention is a deck having an improved mechanism for securing a cassette in place during treatment operations. The improved deck comprises catches for slidably receiving tabs of the cassette and one or more rotating clamps for locking and securing the cassette in a loaded position. In another aspect the invention is a system for controlling and driving blood fluids having infrared communication abilities to transmit and receive real time data. In still another aspect, the invention is a system for controlling and driving blood fluids having an upright tower design that reduces the footprint of the system. In this embodiment, a centrifuge chamber is positioned in an upper portion of the system while the control deck and photoactivation chamber are located in a base portion of the system.Type: GrantFiled: June 1, 2006Date of Patent: December 16, 2008Assignee: Therakos, Inc.Inventors: Mchael Hutchinson, Dennis Briggs, Stephen Gara, Tom Walters
-
Patent number: 7374677Abstract: The present invention relates to a system for two-stage blood dialysis of a patient. In one embodiment, the system comprises a first filtration device for receiving the blood from the patient and for producing a first filtrate and processed blood. The system further comprises a second filtration device for receiving the first filtrate and producing replacement fluid and waste product. At least one of the first and second filtration devices preferably comprises a Taylor vortex-enhanced blood filtration device.Type: GrantFiled: August 20, 2004Date of Patent: May 20, 2008Assignee: KKJ, Inc.Inventors: Jennifer K. McLaughlin, Don Schoendorfer
-
Patent number: 7364562Abstract: A method for maintaining clear passageways in an extracorporeal blood flow system. The method comprises intermittently providing one or more anti-clotting agents to a passageway of the extracorporeal blood flow system. Also disclosed is an extracorporeal blood flow system. The system comprises a passageway, and a device operatively connected to provide one or more anti-clotting agents to a least a portion of said passageway.Type: GrantFiled: December 21, 2005Date of Patent: April 29, 2008Assignee: OptiScan Biomedical Corp.Inventors: James R. Braig, Richard Keenan
-
Patent number: 7354415Abstract: Methods and apparatus particularly involving the separation of blood into blood components and the collection of such components are disclosed. In one aspect, an extra-corporeal method for the collection of plasma and red blood cells is provided, wherein the collection of plasma and red blood cells may occur simultaneously or subsequently utilizing the same dual stage blood processing vessel. The flow of blood to the blood processing vessel and return of uncollected blood components may be provided via a single needle, wherein blood is removed from and returned to a donor/patient during alternating blood removal and blood return submodes. Platelet separation and collection options are also described. In either case, prior to red blood cell collection, a set-up phase may be carried out to set a predetermined hematocrit and AC ratio. Replacement fluid delivery may optionally also be provided either substantially continuously during any collection phase(s) and/or in a bolus mode.Type: GrantFiled: April 20, 2004Date of Patent: April 8, 2008Assignee: Gambro BCT, Inc.Inventors: Marlene Bainbridge, Muriel Keller, Timothy M. Gordon, Michael J. McAteer, Scott D. Butzke
-
Patent number: 7351218Abstract: A device for treating blood by extracorporeal circulation comprising a filter having a first chamber and a second chamber separated by a semi-permeable membrane. The device has an arterial line connected to the first chamber of the filter, a venous line issuing from the first chamber of the filter, a channel used for pre-infusion of a substance for regional anticoagulation and linked to the arterial line, a purge channel issuing from the second chamber of the filter, and an air separator on the venous line. The device also includes a line for post-infusion of a solution at least partially re-establishing the ionic equilibrium of the blood downstream of the air separator, the post-infusion line being configured immediately upstream of an air detector.Type: GrantFiled: December 19, 2003Date of Patent: April 1, 2008Assignee: Gambro Lundia ABInventor: Bernard Bene
-
Patent number: 7314554Abstract: The invention relates to an extracorporeal blood treatment machine in which a blood circuit (3) is equipped with an inlet line leading to a filtration unit (2) and with an outlet line (3b) from the filtration unit; a fluid circuit comprises an inlet line (4a) leading to the filtration unit and an outlet line (4b) from the filtration unit so as to allow a fluid taken from a primary container (5) to circulate within the filtration unit, thus enabling the treatment of the patient's blood. There is further an infusion line (6) acting on the outlet line of the blood circuit, which is supplied by an auxiliary fluid container (7). The inlet line of the fluid circuit is equipped with at least an infusion branch (8) acting on the outlet line of the blood circuit so as to enable the intensive therapy machine to manage therapies with large exchange of fluids.Type: GrantFiled: February 5, 2004Date of Patent: January 1, 2008Assignee: Gambro Lundia ABInventors: Annalisa Delnevo, Francesco Ribolzi, Claudio Tonelli, Vincenzo Baraldi, Massimo Zaccarelli, Jacques Chevallet, Jacques Duchamp, Aziz Aberkane, Gabriel Meyssonnier, Dominique Pouchoulin
-
Patent number: 7217356Abstract: A biological suspension processing system is disclosed that may include a suspension treatment device for treating one or more components of a biological suspension, a first fluid flow path for introducing a suspension into the treatment device and a second fluid flow path for withdrawing a constituent of the suspension from the device. At least one microelectromechanical (MEM) sensor communicates with one of the fluid flow paths for sensing a selected characteristic of the fluid therewith. The MEM sensor may be located elsewhere, such as on a container or bag and communicate with the interior for sensing a characteristic of the fluid contained therein. A wide variety of characteristics may be sensed, such as flow rate, pH, cell type, cell antigenicity, DNA, viral or bacterial presence, cholesterol, hematocrit, cell concentration, cell count, partial pressure, pathogen presence, or viscosity.Type: GrantFiled: August 5, 2005Date of Patent: May 15, 2007Assignee: Fenwal, Inc.Inventors: William H. Cork, James J. Ulmes, Richard L. West, Ying-Cheng Lo, Mark C. Weber, Kyungyoon Min
-
Patent number: 7169547Abstract: A therapeutic product formed from a high concentration of white blood cells having a high degree of cell viability. The white blood cells are sequestered from their normal population presence in whole blood by placing the blood into a container and preventing coagulation of the blood, separating the blood into two components, one of which is extremely rich in white blood cells through the use of a reagent and centrifugation, sequestering the white cell concentration, and freezing the white cells.Type: GrantFiled: May 15, 2001Date of Patent: January 30, 2007Assignee: New York Blood Center, Inc.Inventors: Pablo Rubinstein, Philip Henry Coelho, Cladd E. Stevens
-
Patent number: 7037428Abstract: A system for automatically processing blood components is described. The system includes a console, which contains all motors, pumps, sensors, valves and control circuitry, and a unique disposable set that includes a cassette supporting a centrifuge with an improved design, pump interfaces with an improved design, component and solution bags, and tubing. Various processes are implemented using a specific disposable set for each process which allows automatic identification of the process to be performed the console.Type: GrantFiled: April 18, 2003Date of Patent: May 2, 2006Assignee: Mission Medical, Inc.Inventors: Thomas C. Robinson, Thomas P. Robinson, Richard D'Elia, Paul Eibe, Thomas Sahines
-
Patent number: 6994781Abstract: A biological suspension processing system is disclosed that may include a suspension treatment device for treating one or more components of a biological suspension, a first fluid flow path for introducing a suspension into the treatment device and a second fluid flow path for withdrawing a constituent of the suspension from the device. At least on microelectromechanical (MEM) sensor communicates with one of the fluid flow paths for sensing a selected characteristic of the fluid therewith. The MEM sensor may be located elsewhere, such as on a container or bag and communicate with the interior for sensing a characteristic of the fluid contained therein. A wide variety of characteristics may be sensed, such as flow rate, pH, cell type, cell antigenicity, DNA, viral or bacterial presence, cholesterol, hematocrit, cell concentration, cell count, partial pressure, pathogen presence, or viscosity.Type: GrantFiled: July 3, 2001Date of Patent: February 7, 2006Assignee: Baxter International Inc.Inventors: William H. Cork, James J. Ulmes, Richard L. West, Ying-Cheng Lo, Mark C. Weber, Kyungyoon Min
-
Patent number: 6900231Abstract: Phenyl acetamide compounds are described, including compounds of or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R3-R6, R11, B, Y and W are set forth in the specification. The compounds of the invention are potent inhibitors of proteases, especially trypsin-like serine proteases, such as thrombin and factor Xa. Compositions for inhibiting loss of blood platelets, inhibiting formation of blood platelet aggregates, inhibiting formation of fibrin, inhibiting thrombus formation, and inhibiting embolus formation are described. Other uses of compounds of the invention are as anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage, such as catheters, blood dialysis machines, blood collection syringes and tubes, blood lines and stents. Additionally, the compounds can be detectably labeled and employed for in vivo imaging of thrombi.Type: GrantFiled: October 3, 2002Date of Patent: May 31, 2005Assignee: 3-Dimensional Pharmaceuticals, Inc.Inventors: Wenxi Pan, Tianbao Lu, Thomas P. Markotan, Bruce E. Tomczuk
-
Patent number: 6855120Abstract: An apheresis system is disclosed which may include a separation chamber; a suspension flow path which communicates at one end with the separation chamber and includes a connector at the other end for connecting to a source of cellular suspension; an anticoagulant flow path which communicates at one end with the suspension flow path and includes a connector at the other end for connecting to an anticoagulant source; and a return flow path which communicates at one end with the separation chamber and communicates at the other end with a connector for connection directly to the suspension source or to the suspension flow path for returning one or more suspension components to the source. The anticoagulant flow path includes a flow restriction, such as an internal flow restriction, which limits the free flow of anticoagulants into the suspension flow path while preferably not completely stopping the flow of anticoagulant.Type: GrantFiled: February 24, 2003Date of Patent: February 15, 2005Assignee: Baxter International Inc.Inventor: Daniel J. Grimm
-
Publication number: 20040133145Abstract: The invention concerns a device for treating blood by extracorporeal circulation (101) comprising a filter (102) having a first chamber (103) and a second chamber (104) separated by a semi-permeable membrane (105), an arterial line (106) connected to the first chamber (103) of the filter (102), a venous line (108) issuing from the first chamber (103) of the filter (102), a channel (109) used for pre-infusion of a substance for regional anticoagulation and linked to the arterial line (106), a purge channel (110) issuing from the second chamber (104) of the filter (102), an air separator (112) on the venous line (108), a line (112) for post-infusion of a solution at least partially re-establishing the ionic equilibrium of the blood downstream of the air separator (111), and an air detector (113) downstream of the post-infusion line (112).Type: ApplicationFiled: December 19, 2003Publication date: July 8, 2004Applicants: HOSPAL INTERNATIONAL MARKETING MANAGEMENT snc, GAMBRO LUNDIA AB.Inventor: Bernard Bene
-
Patent number: 6752777Abstract: Platelets are collected from blood by delivering blood from a blood source to a centrifugal separator and operating the separator to separate plasma from the blood. The separated plasma is collected in a plasma collecting bag. After a predetermined amount of plasma has been collected in the bag, the plasma is circulated between the bag and the separator. That procedure is repeated at least once to build-up the amount of collected blood. Then platelets are collected by delivering additional blood to the separator and circulating plasma between the separator and the plasma collecting bag at an accelerating circulation rate while rotating the rotor to remove platelets from the separator. The platelets are collected in a platelet collecting bag. Then, blood remaining in the separator is returned to the blood source.Type: GrantFiled: October 5, 1999Date of Patent: June 22, 2004Assignee: Terumo Kabushiki KaishaInventors: Yoshiki Takagi, Atsushi Suzuki
-
Patent number: 6743191Abstract: The invention relates to a substitution infusion fluid for hemofiltration of a specific composition. The use of said substitution infusion fluid significantly reduces the risk of the occurrence of abnormalities in a patient undergoing pure hemofiltration. The invention also relates to process for pure hemofiltration of blood wherein said substitution infusion fluid is used. The invention also relates to a matching citrate anticoagulation fluid of a specific composition. The invention also relates to a process for pure hemofiltration of blood wherein said substitution infusion fluid is used in combination with said citrate anticoagulation fluid. The use of said substitution infusion fluid in combination with said citrate anticoagulation fluid significantly further reduces the risk of the occurrence of abnormalities in a patient undergoing pure hemofiltration.Type: GrantFiled: October 23, 2001Date of Patent: June 1, 2004Assignee: Edwards Lifesciences AGInventor: Pe Chou Chang
-
Patent number: 6713246Abstract: The present invention relates to a method for producing interleukin-1 receptor antagonists, a prophylatically or therapeutically effective protein. A syringe is filled with a body fluid and incubated. The prophylatically or therapeutically effective protein is then produced in the body fluid.Type: GrantFiled: August 1, 2001Date of Patent: March 30, 2004Assignee: Orthogen AGInventors: Julio Reinecke, Hans Meijer, Peter Wehling
-
Patent number: 6565806Abstract: An apheresis system is disclosed which may include a separation chamber; a suspension flow path which communicates at one end with the separation chamber and includes a connector at the other end for connecting to a source of cellular suspension; an anticoagulant flow path which communicates at one end with the suspension flow path and includes a connector at the other end for connecting to an anticoagulant source; and a return flow path which communicates at one end with the separation chamber and communicates at the other end with a connector for connection directly to the suspension source or to the suspension flow path for returning one or more suspension components to the source. The anticoagulant flow path includes a flow restriction, such as an internal flow restriction, which limits the free flow of anticoagulants into the suspension flow path while preferably not completely stopping the flow of anticoagulant.Type: GrantFiled: March 13, 1998Date of Patent: May 20, 2003Assignee: Baxter International Inc.Inventor: Daniel J. Grimm
-
Patent number: 6544206Abstract: A method of and system for providing vascular access in a patient for hemodialysis involves attaching the distal end of an access catheter to the abdominal aorta of the patient and the proximal end of the access catheter to a portion of the patient to allow selective access to an interior portion of the access catheter. A blood-withdrawal catheter and a blood-return catheter are placed into the access catheter until their distal ends are in the patients abdominal aorta and blood may be removed and return to the aorta. When finished, the blood catheters are removed. Selective access to the proximal end of the access catheter is provided, preferably, by a cutaneous port assembly that includes a screwable cap and anti-infection cuff.Type: GrantFiled: October 13, 2000Date of Patent: April 8, 2003Inventor: Robert H. Johnston, Jr.
-
Patent number: 6527957Abstract: Methods are disclosed for the collection of red blood cells whereby whole blood is combined with an anticoagulant, red cells are separated from the whole blood and the separated red cells are combined with a storage solution. The red cells may be stored for an extended period of time.Type: GrantFiled: April 7, 1999Date of Patent: March 4, 2003Assignee: Baxter International Inc.Inventors: Jose C. Deniega, Daniel H. Duff, Maria D. Gudino, Donald H. Buchholz
-
Patent number: 6511439Abstract: A blood-collecting device comprises an outer cylinder, a gasket slidable in the outer cylinder, and a plunger for the moving operation of the gasket. A ventilatable filter member is mounted on the tip end part of a hole formed in the gasket. The hole communicated with the outside via the hole of the plunger and the internal space. An anti-coagulation agent supply piece with an anti-coagulation agent such as a heparin supported on one side or both sides of a plate-like supporting member is provided in a space surrounded by the outer cylinder and the gasket. The tip end side of the anti-coagulation agent supply piece having a shape tapered toward the blood inlet opening, and the anti-coagulation agent supply piece maintains its posture by linear contact of a pair of sides facing with each other with the inner surface of the outer cylinder.Type: GrantFiled: December 4, 2000Date of Patent: January 28, 2003Assignee: Terumo Kabushiki KaishaInventors: Yasushi Tabata, Yasuhiro Ishiguro, Yukio Koshimura, Nobuo Yoshino
-
Patent number: 6508778Abstract: The invention comprises a disposable tubing set (4) for connection to a rigid canister (2) that is maintained at a controlled reduced (vacuum) pressure.Type: GrantFiled: November 29, 2000Date of Patent: January 21, 2003Assignee: Harvest Technologies CorporationInventors: Wesley H. Verkaart, Thomas G. Crimi
-
Publication number: 20020107469Abstract: An apheresis method that includes drawing blood from a mammal, adding an amount of an agent effective in preventing coagulation, wherein the agent is an anticoagulant, extracting one or more constituent components from the blood, wherein an extracted blood and constituent component result therefrom, and diminishing the activity of said anticoagulant by introducing an antidote, wherein the amount of antidote introduced is coupled with the amount of anticoagulant added. The antidote is provided either to the processed blood prior to reintroduction to the donor or directly to the donor. The invention also includes an apheresis machine that includes an antidote delivery conduit, wherein the antidote delivery conduit delivers an amount of antidote that is coupled with an amount of anticoagulant delivered.Type: ApplicationFiled: November 2, 2001Publication date: August 8, 2002Inventors: Charles Bolan, Susan F. Leitman, Herb Cullis
-
Publication number: 20010003794Abstract: Disclosed herein is an apparatus that efficiently clears solutes from blood of patients with renal disease solely by convection and with a single filter that includes a hemofilter, a blood pump for drawing blood from a patient and propelling the blood into a mixing chamber, a mixing and detention chamber where the blood and a non-isosmotic diluent are mixed and are allowed to approach or reach equilibrium (with regard to solute concentration), a mixing element for creating turbulence in the mixing/detention chamber, and suitable tubing for carrying the pumped blood to and from the patent. Methods for utilizing the apparatus are also disclosed.Type: ApplicationFiled: May 22, 1998Publication date: June 14, 2001Applicant: Nehhros, Inc.Inventors: DONALD W. LANDRY, HOWARD R. LEVIN, EVAN STUART GARFEIN